BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 18224401)

  • 1. Whole-breast radiotherapy with shorter fractionation schedules following breast-conserving surgery: short-term morbidity and preliminary outcomes.
    Fujii O; Hiratsuka J; Nagase N; Tokiya R; Yoden E; Sonoo H; Murashima N; Iha S; Imajyo Y
    Breast Cancer; 2008; 15(1):86-92. PubMed ID: 18224401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
    Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F
    Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
    Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
    Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypofractionated radiotherapy for breast cancer patients treated by breast-conserving surgery: short-term morbidity and preliminary results.
    Plataniotis GA; Theofanopoulou MA; Sotiriadou K; Kyrgias G
    Breast Cancer; 2010; 17(1):42-7. PubMed ID: 19350358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conservative management of Paget disease of the breast with radiotherapy: 10- and 15-year results.
    Marshall JK; Griffith KA; Haffty BG; Solin LJ; Vicini FA; McCormick B; Wazer DE; Recht A; Pierce LJ
    Cancer; 2003 May; 97(9):2142-9. PubMed ID: 12712465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer first results of the randomized Budapest boost trial.
    Polgár C; Fodor J; Orosz Z; Major T; Takácsi-Nagy Z; Mangel LC; Sulyok Z; Somogyi A; Kásler M; Németh G
    Strahlenther Onkol; 2002 Nov; 178(11):615-23. PubMed ID: 12426672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary results of electron intraoperative therapy boost and hypofractionated external beam radiotherapy after breast-conserving surgery in premenopausal women.
    Ivaldi GB; Leonardi MC; Orecchia R; Zerini D; Morra A; Galimberti V; Gatti G; Luini A; Veronesi P; Ciocca M; Sangalli C; Fodor C; Veronesi U
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):485-93. PubMed ID: 18407434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy confined to the tumor bed following breast conserving surgery current status, controversies, and future projects.
    Polgár C; Fodor J; Major T; Takácsi-Nagy Z; Kásler M; Hammer J; Van Limbergen E; Németh G
    Strahlenther Onkol; 2002 Nov; 178(11):597-606. PubMed ID: 12426670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute radiation dermatitis and pneumonitis in Japanese breast cancer patients with whole breast hypofractionated radiotherapy compared to conventional radiotherapy.
    Osako T; Oguchi M; Kumada M; Nemoto K; Iwase T; Yamashita T
    Jpn J Clin Oncol; 2008 May; 38(5):334-8. PubMed ID: 18417501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor bed boost omission after negative re-excision in breast-conservation treatment.
    Arthur DW; Cuttino LW; Neuschatz AC; Koo DT; Morris MM; Bear HD; Kaplan BJ; Dawson K; Wazer DE
    Ann Surg Oncol; 2006 Jun; 13(6):794-801. PubMed ID: 16614879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery.
    Veronesi U; Gatti G; Luini A; Intra M; Ciocca M; Sanchez D; Zurrida S; Navarro S; Orecchia R
    Arch Surg; 2003 Nov; 138(11):1253-6. PubMed ID: 14609877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innovations in radiation therapy (RT) for breast cancer.
    Lee LJ; Harris JR
    Breast; 2009 Oct; 18 Suppl 3():S103-11. PubMed ID: 19914528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
    Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G
    Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local control with conventional and hypofractionated adjuvant radiotherapy after breast-conserving surgery for ductal carcinoma in-situ.
    Williamson D; Dinniwell R; Fung S; Pintilie M; Done SJ; Fyles AW
    Radiother Oncol; 2010 Jun; 95(3):317-20. PubMed ID: 20400190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast-conserving treatment in the elderly: long-term results of adjuvant hypofractionated and normofractionated radiotherapy.
    Kirova YM; Campana F; Savignoni A; Laki F; Muresan M; Dendale R; Bollet MA; Salmon RJ; Fourquet A;
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):76-81. PubMed ID: 19168297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of IMRT for breast cancer: a single-institution cohort analysis.
    McDonald MW; Godette KD; Butker EK; Davis LW; Johnstone PA
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1031-40. PubMed ID: 18440727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of the boost technique on local control in breast conserving treatment in the EORTC 'boost versus no boost' randomised trial.
    Poortmans P; Bartelink H; Horiot JC; Struikmans H; Van den Bogaert W; Fourquet A; Jager J; Hoogenraad W; Rodrigus P; Wárlám-Rodenhuis C; Collette L; Pierart M;
    Radiother Oncol; 2004 Jul; 72(1):25-33. PubMed ID: 15236871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage.
    Monteau A; Sigal-Zafrani B; Kirova YM; Fourchotte V; Bollet MA; Vincent-Salomon A; Asselain B; Salmon RJ; Fourquet A
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1021-8. PubMed ID: 19386441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of breast-conserving therapy for breast cancer.
    Shimauchi A; Nemoto K; Ogawa Y; Kakuto Y; Sakayauchi T; Takai Y; Ishida T; Ohuchi N; Hirakawa H; Kimura M; Yamada T; Takahashi S; Yamada S
    Radiat Med; 2005 Nov; 23(7):485-90. PubMed ID: 16485539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of a prospective policy of margin-directed radiation dose escalation in breast-conserving therapy.
    Neuschatz AC; DiPetrillo T; Safaii H; Price LL; Schmidt-Ullrich RK; Wazer DE
    Cancer; 2003 Jan; 97(1):30-9. PubMed ID: 12491502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.